MPO and colitis: In addition, GW9662 markedly weakened the anti-colitis effect of MA as evidenced by higher DAI (Fig. 7d), shorter colon length (Fig. 7e), higher MPO activity (Fig. 7f), and more serious pathological lesion (Fig. 7g) in the colon tissues.